Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis

NCT02135536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Biliary Cirrhosis

Interventions

BIOLOGICAL: NGM282

Sponsor

NGM Biopharmaceuticals, Inc

Collaborators

[object Object]